More Upcoming Events

TechCrunch Live with Future Ventures and Cambrian Biopharma

Wednesday, May 3 at 11:30am PT / 2:30pm ET

Cambrian Biopharma bills itself as a new pharmaceutical company with a revolutionary approach to developing and managing drug development. James Peyer, Ph.D co-founded the company in 2019, and it has since raised over $180 million to accelerate the development of medicine designed to target the causes of age-related diseases. But that’s not the interesting part. Peyer’s executive team has managed to attract top talent by giving them an oversized amount of equity compared to traditional pharmaceutical companies. 

Maryanna Saenko of Future Ventures is also speaking at this TechCrunch Live event. She sits on Cambrian Biopharma’s board of directors and invested in the company’s Series A, B, and C rounds. Together, the two are going to break down Cambrian Biopharma’s unique business model and explain why this process works so well.

Register Here